Detalhe da pesquisa
1.
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program.
Pharmacoepidemiol Drug Saf
; 33(5): e5799, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680102
2.
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom.
Pharmacoepidemiol Drug Saf
; 30(2): 237-247, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091194
3.
Challenges facing drug utilization research in the Latin American region.
Pharmacoepidemiol Drug Saf
; 29(11): 1353-1363, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419226
4.
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study.
Drug Saf
; 44(8): 899-915, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236595
5.
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder.
Curr Med Res Opin
; 37(5): 867-877, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591859
6.
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.
Clin Epidemiol
; 12: 423-433, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32431551
7.
Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases.
Drugs Real World Outcomes
; 5(1): 25-34, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29134621
8.
Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study.
Pharmacotherapy
; 38(6): 628-637, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723926
9.
Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.
Basic Clin Pharmacol Toxicol
; 122(6): 612-619, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29345103
10.
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.
PLoS One
; 13(9): e0204456, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260993